Aine Sons
Family · Sterling Heights, MINPI 1437682317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $573 and has fallen 90.7% since, to $53 in 2025.
Across 70 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$236
- AbbVie$137
- Mallinckrodt Hospital Products Inc.$136
- Biohaven Pharmaceutical Holding Company Ltd.$100
- Fresenius USA Marketing, Inc.$64
- Novartis$61
- plus $597 from 19 others
What the payments were for
- Food & beverage$1,332100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 8 | $236 |
| AbbVie | 9 | $137 |
| Mallinckrodt Hospital Products Inc. | 6 | $136 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $100 |
| Fresenius USA Marketing, Inc. | 3 | $64 |
| Novartis | 3 | $61 |
| Calliditas Therapeutics US Inc. | 3 | $55 |
| Johnson & Johnson | 4 | $55 |
| Lilly USA, LLC | 3 | $54 |
| Amgen | 2 | $49 |
| SK Life Science, Inc. | 3 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| UCB, Inc. | 2 | $33 |
| Bayer | 2 | $32 |
| Merck | 2 | $31 |
| Aurinia Pharma U.S., Inc. | 1 | $30 |
| GSK | 1 | $30 |
| Seqirus USA Inc | 2 | $27 |
| Travere Therapeutics, Inc. | 2 | $25 |
| Vifor Pharma, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPHOZAH 30 MG$117
How this compares
$1,332 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProsolParenteral Amino Acid 20% No.1 | 278 | $44,261 |
| Lanthanum Carbonate | 31 | $28,916 |
| Sevelamer Carbonate | 40 | $7,780 |
| Calcium Acetate | 40 | $3,727 |
| ClinisolParenteral Amino Acid 15% No.5 | 11 | $1,986 |
| Hydralazine Hcl | 44 | $986 |
| Midodrine Hcl | 17 | $501 |
| Carvedilol | 43 | $490 |
| Tamsulosin Hcl | 13 | $299 |
| Amlodipine Besylate | 48 | $256 |
| Metoprolol Succinate | 21 | $231 |
| Losartan Potassium | 19 | $192 |
| Omeprazole | 16 | $152 |
| Clonidine Hcl | 22 | $141 |
| Atorvastatin Calcium | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other family in Sterling Heights
- Simona DenkovskiSterling Heights$11K
- Brittany SharpSterling Heights$10K
- Darlene BrownSterling Heights$9K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.